6505--Radiopharmaceuticals Base Plus Four Option Years VA San Diego Healthcare System
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
262-NETWORK CONTRACT OFFICE 22 (36C262)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C26227Q0091
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Department of Veterans Affairs, through its Network Contract Office 22 (NCO 22), has issued a Sources Sought Notice (Procurement Identifier: 36C26227Q0091) for the manufacturing and delivery of sterile, aseptic, USP 825-compliant, low enriched uranium (LEU) radiopharmaceuticals. This requirement is intended to support the diagnostic and therapeutic needs of patients served by the Nuclear Medicine Service at the VA San Diego Healthcare System, located at 3350 La Jolla Village Drive, San Diego, CA 92161.
Purpose and Scope:
The primary objective of this procurement is to ensure a reliable supply of radiopharmaceuticals for the VA San Diego Healthcare System over a five-year period, comprising a base year (January 1, 2027 – December 31, 2027) and four option years extending through December 31, 2031. The radiopharmaceuticals will be used for both routine and emergency nuclear medicine procedures, including research applications as requested. The scope encompasses not only the manufacturing and delivery of these products but also compliance with all relevant safety, regulatory, and quality standards.
Key Requirements and Deliverables:
- All radiopharmaceuticals must be manufactured and delivered in accordance with USP 825 standards and must utilize low enriched uranium (LEU).
- Delivery services must comply with Department of Transportation (DOT) regulations for the shipment of radioactive drugs.
- Stat (emergency) delivery services must be available 24 hours a day, 365 days a year, with delivery within one hour of request.
- Routine orders require next-business-day delivery unless otherwise specified.
- Dose labels must be compatible with the Nuclear Medicine Information System (NMIS) computerized radiopharmacy database.
- The contractor must provide storage, preparation, labeling, and delivery of research radiopharmaceuticals as needed.
- Packaging and marking must adhere to all local, state, and federal regulations, with clear identification of purchase, obligation, and contract numbers.
- Immediate notification and remediation are required for any recalled or defective products.
- All functions must comply with OSHA, FDA, NRC, Joint Commission, and DOT safety guidelines. Delivery personnel must be trained in radiation safety and regulatory requirements.
- Contractor personnel must wear company-branded clothing and badges, possess photo identification, and be able to communicate in English.
- Vehicles must display the company name, and parking must be in designated areas as directed by VA security.
- Invoices are to be submitted monthly, with detailed information for proper identification and payment processing.
Product List:
The notice includes a comprehensive list of radiopharmaceuticals and related supplies, such as I-123 and I-131 sodium iodide capsules, In-111 products, 99mTc compounds, Tl-201, Ga-67, GA-68 DOTATATE, and various kits and syringes. Estimated minimum quantities and unit of measure are provided for each item.
Contracting Entity and Classification:
- Contracting Entity: Network Contract Office 22 (NCO 22), Department of Veterans Affairs
- Place of Performance: San Diego, CA
- NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing), size standard 1,300 employees
- Product Service Code: 6505 (Drugs and Biologicals)
- Contact: Adrienne Brown, [email protected], 951-601-4536
Procurement Type and Special Considerations:
This notice is a Request for Information (RFI) and Sources Sought, not a solicitation. The government seeks information from potential qualified sources regarding their capabilities, market pricing, and delivery options. Responses will inform future acquisition decisions and may lead to further RFIs or a formal solicitation. The procurement is subject to VAAR 852.212-71, prohibiting gray market and counterfeit items; only original equipment manufacturers (OEMs), authorized dealers, distributors, or resellers verified by OEM authorization are eligible. Brand name or equal products are required, and quoters must demonstrate compliance with salient characteristics.
Set-Aside and Business Status:
Respondents are asked to indicate their business size and status (e.g., SDVOSB, VOSB, HUBZone, WOSB, Large Business) relative to the NAICS code. Compliance with limitations on subcontracting and the Non-Manufacturer Rule is required, and respondents must confirm whether their products are Commercial Off-The-Shelf (COTS) and conform to the Buy American Act.
Submission Instructions:
Interested and capable companies should submit a capabilities statement addressing each requirement, business size/status, manufacturer/distributor status, compliance with regulatory and contractual requirements, and general pricing information for market research purposes. Responses must be submitted via email to Adrienne Brown by 10AM Mountain Time on Friday, November 6, 2026. Telephone responses will not be accepted.
Constant Elements:
Throughout the contract lifecycle, the requirement for compliance with safety, regulatory, and quality standards, the need for reliable and timely delivery of radiopharmaceuticals, and the prohibition of gray market or counterfeit items will remain unchanged. The VA San Diego Healthcare System will continue to be the place of performance, and the contracting entity will remain NCO 22 under the Department of Veterans Affairs.
For further details and to review the full notice, visit the SAM.gov opportunity at: https://sam.gov/opp/df49ac63c84d4ff39cec5afa37bc9132/view
This opportunity is ideal for contractors with proven capabilities in pharmaceutical preparation manufacturing, particularly those experienced in radiopharmaceuticals, regulatory compliance, and high-reliability delivery services for healthcare institutions.